CRT-D therapy in patients with left ventricular dysfunction and atrial fibrillation

Annals of Noninvasive Electrocardiology

Volumn 10, Issue SUPPL. 4, 2005, Pages 55-58

  Pelosi Jr , Frank ^a,b   Morady, Fred ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b Box 0311 ^*  (United States)

Author keywords

Atrial fibrillation; Biventricular pacing; Cardiac resynchronization therapy; Congestive heart failure

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; EXERCISE TOLERANCE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE PACING; HUMAN; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; SINUS RHYTHM; TREATMENT OUTCOME; CLINICAL PRACTICE; CLINICAL TRIAL; HEART LEFT VENTRICLE FUNCTION; PRACTICE GUIDELINE; REVIEW;

ATRIAL FIBRILLATION; CLINICAL TRIALS; HEART FAILURE, CONGESTIVE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33644795801     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2005.00072.x     Document Type: Conference Paper

References (24)

1. Chugh SS, Blackshear JL, Shen WK, et al. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001;37:371-8.
2. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-350.
3. Khairallah F, Ezzedine R, Ganz LI, et al. Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001. Am J Cardiol 2004;94:500-504.
4. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: Implications for primary prevention. Circulation 2003;108:711-716.
5. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study (see comment). Circulation 2003;107:2920-2925.
6. Deedwania PC, Singh BN, Ellenbogen K, et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation 1998;98:2574-9.
7. Hsu LF, Jais P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure(see comment). N Engl J Med 2004;351:2373-2383.
8. Pozzoli M, Cioffi G, Traversi E, et al. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: A prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 1998;32(1):197-204.
9. Yamada T, Fukunami M, Shimonagata T, et al. Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: A prospective study. J Am Coll Cardiol 2000;35:405-413.
10. van den Berg MP, Tjeerdsma G, Jan de Kam P, et al. Long-standing atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure. Eur J Heart Failure 2002;4:255-262.
11. Tuinenburg AE, Van Veldhuisen DJ, Boomsma F, et al. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol 1998;81:1207-1210.
12. Li D, Melnyk P, Feng J, et al. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 2000;101:2631-2638.
13. Bode F, Sachs F, Franz MR. Tarantula peptide inhibits atrial fibrillation. Nature 2001;409:35-36.
14. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure.[see comment]. N Engl J Med 2002;346:1845-1853.
15. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure (see comment). N Engl J Med 2004;350:2140-2150.
16. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure (see comment). N Engl J Med 2005;352:1539-1549.
17. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial (see comment). JAMA 2002;288:3115-3123.
18. Leon AR, Greenberg JM, Kanuru N, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002;39:1258-1263.
19. Garrigue S, Bordachar P, Reuter S, et al. Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: Prospective haemodynamic study. Heart (Br Cardiac Soc) 2002;87:529-534.
20. Molhoek SG, Bax JJ, Bleeker GB, et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol 2004;94:1506-1509.
21. Indik JH. Spontaneous conversion of atrial fibrillation in the setting of biventricular pacing. Cardiol Rev 2004;12:1-2.
22. Malinowski K. Spontaneous conversion of permanent atrial fibrillation into stable sinus rhythm after 17 months of biventricular pacing. PACE 2003;26(Pt 1):1554-1555.
23. Padeletti L, Musilli N, Porciani MC, et al. Atrial fibrillation and cardiac resynchronization therapy: The MASCOT study. Europace 2004;5(Suppl 1):S49-S54.
24. Anonymous. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. Am Heart J 2002;144:597-607.